DiviDrip · EPRX

EPRX — Eupraxia Pharmaceuticals Inc.

EPRX is Eupraxia Pharmaceuticals Inc. (Healthcare) — a non-dividend-paying stock. Trading at $8.40. Market cap: $555M. Capital Quality Rank: 52/100 — Above average.

Stock snapshot

Price$8.40
Market cap$555M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)52 / 100 · Above average
Shareholder buyback yield-15.08%
Altman Z-score zoneSafe

About EPRX

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.

Listed2021Employees49SectorHealthcareWebsiteeupraxiapharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside EPRX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is EPRX's current stock price?

EPRX (Eupraxia Pharmaceuticals Inc.) is currently trading at $8.40.

Does EPRX pay a dividend?

EPRX (Eupraxia Pharmaceuticals Inc.) does not currently pay a regular dividend.

What is EPRX's Capital Quality Rank?

EPRX has a Capital Quality Rank of 52/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track EPRX in DiviDrip

Add EPRX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow